The effects of fibrates on lipoprotein and hemostatic coronary risk factors
- PMID: 7718018
- DOI: 10.1016/0021-9150(94)90090-6
The effects of fibrates on lipoprotein and hemostatic coronary risk factors
Abstract
The effects of fibrates on lipoprotein profiles and lipoprotein physiology, as well as on selected coagulation and fibrinolytic factors are reviewed. It is concluded that the action of fibrates on these systems is such as to render the fibrates beneficial in atherosclerosis prevention.
Similar articles
-
Drug interactions with fibric acids.Pharmacol Ther. 1994 Aug;63(2):163-76. doi: 10.1016/0163-7258(94)90043-4. Pharmacol Ther. 1994. PMID: 7809177 Review.
-
Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.Drugs Today (Barc). 2006 Jan;42(1):39-64. doi: 10.1358/dot.2006.42.1.963528. Drugs Today (Barc). 2006. PMID: 16511610 Review.
-
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.Curr Med Res Opin. 2007 May;23(5):1103-11. doi: 10.1185/030079907x187892. Curr Med Res Opin. 2007. PMID: 17519077 Review.
-
Fibrates, dyslipoproteinaemia and cardiovascular disease.Curr Opin Lipidol. 1999 Dec;10(6):561-74. doi: 10.1097/00041433-199912000-00011. Curr Opin Lipidol. 1999. PMID: 10680050 Review.
-
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.Eur J Clin Pharmacol. 1991;40(1):33-41. doi: 10.1007/BF00315136. Eur J Clin Pharmacol. 1991. PMID: 2060543
Cited by
-
Update on the use of fibrates: focus on bezafibrate.Vasc Health Risk Manag. 2008;4(1):131-41. doi: 10.2147/vhrm.2008.04.01.131. Vasc Health Risk Manag. 2008. PMID: 18629356 Free PMC article. Review.
-
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.Int J Nanomedicine. 2006;1(2):129-47. doi: 10.2147/nano.2006.1.2.129. Int J Nanomedicine. 2006. PMID: 17722529 Free PMC article. Review.
-
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.EMBO J. 1996 Oct 1;15(19):5336-48. EMBO J. 1996. PMID: 8895578 Free PMC article.
-
Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.Biochem J. 2003 Feb 1;369(Pt 3):539-47. doi: 10.1042/BJ20020981. Biochem J. 2003. PMID: 12381268 Free PMC article.
-
Polymorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians.Atherosclerosis. 2008 Jun;198(2):313-9. doi: 10.1016/j.atherosclerosis.2007.10.004. Epub 2007 Dec 3. Atherosclerosis. 2008. PMID: 18061194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical